Cormedix inc. (CRMD)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
ASSETS
Current assets
Cash and cash equivalents

12,204

16,350

20,145

14,561

18,256

17,623

6,443

4,701

8,162

10,379

5,212

7,937

6,818

8,064

9,826

12,020

13,184

11,817

14,246

24,110

8,799

4,339

5,920

7,651

9,189

2,373

483

158

692

835

992

893

1,855

1,985

2,889

4,738

8,283

Restricted cash

171

174

170

171

171

171

171

171

171

171

171

171

171

171

171

171

171

171

171

131

131

0

0

0

220

220

220

-

-

0

-

-

-

-

-

-

-

Short-term investments

10,983

11,984

12,294

11,824

7,944

-

0

0

0

1,604

6,796

10,884

6,950

12,100

16,826

16,590

17,043

23,568

23,604

13,377

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Trade receivables, net

-

-

-

-

-

-

-

-

-

64

-

-

-

12

-

-

-

315

-

-

-

80

-

-

-

2

-

-

-

0

-

-

-

-

-

-

-

Trade receivables

7

0

3

0

34

10

302

3

8

-

89

153

75

-

22

6

344

-

124

112

69

-

46

55

14

-

-

-

-

-

-

-

-

-

-

-

-

Total

294

338

381

402

419

428

341

672

578

594

299

313

94

166

118

157

333

376

699

715

461

463

677

278

63

80

270

-

-

0

-

-

-

-

-

-

-

Prepaid research and development expenses

-

-

-

-

-

-

-

-

-

86

-

-

-

943

-

-

-

430

-

-

-

0

0

0

2

6

2

0

5

11

16

0

9

19

13

30

205

Prepaid research and development expenses

37

34

61

248

2

8

15

22

80

-

890

1,281

529

-

1,323

2,059

2,171

-

86

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

20

20

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

13

204

201

257

156

-

-

0

-

-

-

Deferred financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

15

-

-

-

-

-

Security deposit

-

-

-

-

-

-

-

-

-

-

5

5

5

5

5

5

5

5

5

5

18

18

13

13

13

13

13

13

13

13

13

13

13

13

13

13

13

Other receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

493

-

-

280

Total

3,561

446

526

203

312

422

595

168

401

367

392

352

223

372

470

169

319

379

327

298

224

155

140

203

223

232

29

15

50

30

72

105

147

31

99

149

42

Total current assets

27,281

29,349

33,582

27,412

27,142

18,665

7,870

5,740

9,403

13,267

13,852

21,093

14,865

21,831

28,759

31,175

33,569

37,058

39,260

38,746

9,686

5,037

6,784

8,187

9,714

2,916

1,020

378

950

877

1,237

999

2,012

2,530

3,002

4,918

8,812

Property and equipment, net

118

126

134

146

165

160

178

185

205

186

71

56

63

69

75

31

34

37

41

44

47

41

46

54

33

36

3

3

4

4

6

8

9

11

14

17

22

TOTAL ASSETS

27,399

29,475

33,717

27,559

27,308

18,825

8,048

5,926

9,608

13,453

13,928

21,155

14,933

21,906

28,840

31,212

33,609

37,101

39,306

38,796

9,751

5,097

6,845

8,255

9,761

2,967

1,036

395

967

1,153

1,257

1,036

2,035

2,556

3,030

4,949

8,847

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities
Accounts payable

1,333

1,024

1,054

906

1,462

2,588

7,882

7,308

3,659

1,808

1,408

1,765

1,726

1,645

1,758

1,108

1,581

1,709

1,424

1,141

1,428

893

740

848

1,027

939

874

1,394

1,217

928

917

993

1,424

913

990

1,436

1,139

Total

4,470

4,800

3,947

3,433

2,863

5,166

9,650

5,080

5,090

4,363

2,757

2,041

2,062

2,342

3,149

1,876

1,346

1,221

1,450

761

682

521

475

256

46

713

755

313

251

261

599

172

173

296

1,288

262

436

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

1,880

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

88

-

-

-

104

22

24

26

130

33

33

35

10

39

-

-

0

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

2

4

6

8

11

13

15

17

-

86

101

100

-

131

132

135

-

6

9

9

-

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

19

15

15

16

1

-

-

0

-

-

-

Senior convertible notes, net of debt discount of $647,939 in 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

166

207

16

42

-

-

0

-

-

-

Senior convertible notes  related parties, net of debt discount of $406,316 in 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

420

529

391

253

125

-

-

0

-

-

-

Dividend payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

75

48

21

-

-

-

0

-

-

-

-

-

-

-

8% senior convertible notes, net of original issue discount of $10,124 at September 30, 2013 and $0 at December 31, 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

311

-

-

-

-

-

-

-

-

-

-

8% senior convertible notes, related party, net of original issue discount of $25,416 at September 30, 2013 and $0 at December 31, 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

802

-

-

-

-

-

-

-

-

-

-

Warrant Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

582

-

-

-

-

-

-

-

-

-

-

Total current liabilities

5,803

5,826

5,006

4,346

4,334

7,766

17,546

12,404

8,768

6,260

4,252

5,789

3,889

4,091

5,038

3,117

3,063

3,061

2,881

1,911

2,119

1,425

1,227

1,180

1,122

1,674

3,766

2,419

2,082

1,476

1,686

1,166

1,598

1,210

2,278

1,699

1,575

Operating lease liabilities, net of current portion

2

2

3

3

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Convertible note, related party, net

-

-

-

6,734

6,427

6,125

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

8,670

12,361

5,308

-

-

-

0

-

-

-

-

-

-

-

Deferred rent, long term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

5

6

7

8

9

10

12

12

13

13

14

15

15

16

Deferred revenue, long term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28

-

-

-

37

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

TOTAL LIABILITIES

5,806

5,829

5,009

11,084

10,766

13,891

17,546

12,404

8,768

6,260

4,252

5,789

3,889

4,091

5,061

3,142

3,090

3,090

2,914

1,945

2,155

1,463

1,267

9,856

13,490

6,990

3,775

2,428

2,093

1,488

1,699

1,179

1,612

1,224

2,293

1,715

1,592

COMMITMENTS AND CONTINGENCIES

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

-

0

0

0

0

0

-

-

0

0

-

0

0

0

-

0

0

0

STOCKHOLDERS’ EQUITY
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 241,623 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

-

-

0

-

-

-

Common stock - $0.001 par value: 160,000,000 shares authorized; 26,127,067 and 25,665,350 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively

26

25

25

23

23

21

98

85

81

71

61

59

40

40

40

37

36

35

35

34

27

22

22

21

21

16

15

13

11

11

11

11

11

11

11

11

11

Deferred stock issuances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Accumulated other comprehensive income

90

97

102

104

95

96

90

97

97

98

94

96

90

81

83

90

92

62

99

92

101

98

116

-1

-10

-9

-

-

-

0

-

-

-

-

-

-

-

Additional paid-in capital

222,455

218,944

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

-

-

218,696

201,198

200,578

183,803

171,448

164,239

163,003

159,197

151,383

147,117

137,673

136,857

136,291

131,452

129,012

128,304

126,781

122,560

89,167

79,716

79,427

67,332

68,749

51,720

49,539

47,693

46,651

45,886

45,057

44,327

44,269

44,172

44,014

43,911

43,480

Accumulated deficit

-200,978

-195,421

-190,116

-184,852

-184,155

-178,988

-181,136

-170,900

-162,342

-152,174

-141,864

-131,908

-126,761

-119,164

-112,635

-103,509

-98,622

-94,391

-90,525

-85,836

-81,701

-76,204

-73,989

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

68,954

72,491

55,750

52,294

49,741

47,790

46,233

45,510

44,481

43,857

42,852

43,288

40,688

36,236

TOTAL STOCKHOLDERS’ EQUITY

21,593

23,646

28,707

16,475

16,541

4,934

-9,497

-6,478

840

7,193

9,676

15,365

11,043

17,814

23,779

28,070

30,519

34,011

36,391

36,850

7,596

3,634

5,577

-1,600

-3,729

-4,022

-2,738

-2,033

-1,126

-335

-441

-143

423

1,331

737

3,234

7,255

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

27,399

29,475

33,717

27,559

27,308

18,825

8,048

5,926

9,608

13,453

13,928

21,155

14,933

21,906

28,840

31,212

33,609

37,101

39,306

38,796

9,751

5,097

6,845

8,255

9,761

2,967

1,036

395

967

1,153

1,257

1,036

2,035

2,556

3,030

4,949

8,847